CAD 0.56
(3.7%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 134.69 Million USD | -13.75% |
2022 | 156.16 Million USD | 43.89% |
2021 | 108.53 Million USD | 110.78% |
2020 | 51.49 Million USD | 45.06% |
2019 | 35.49 Million CAD | 0.0% |
2017 | 127.14 Thousand CAD | 19.95% |
2016 | 106 Thousand USD | -68.62% |
2015 | 337.75 Thousand USD | -64.53% |
2014 | 952.32 Thousand CAD | -36.77% |
2013 | 1.5 Million CAD | -2.93% |
2012 | 1.55 Million CAD | -53.88% |
2011 | 3.36 Million CAD | 67.47% |
2010 | 2 Million CAD | 7404.29% |
2009 | 26.77 Thousand CAD | -27.88% |
2008 | 37.12 Thousand CAD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q2 | 24.16 Million USD | -14.35% |
2024 Q1 | 28.21 Million USD | -30.9% |
2023 FY | 134.69 Million USD | -13.75% |
2023 Q3 | 25.68 Million USD | -5.4% |
2023 Q2 | 27.15 Million USD | -16.33% |
2023 Q1 | 32.45 Million USD | -17.04% |
2023 Q4 | 40.82 Million USD | 58.92% |
2022 Q4 | 39.11 Million USD | -3.63% |
2022 Q2 | 38.66 Million USD | 4.72% |
2022 Q1 | 36.92 Million USD | -3.64% |
2022 FY | 156.16 Million USD | 43.89% |
2022 Q3 | 40.59 Million USD | 4.98% |
2021 Q2 | 24.9 Million USD | 18.86% |
2021 Q1 | 20.95 Million USD | 20.06% |
2021 Q4 | 38.31 Million USD | 57.36% |
2021 Q3 | 24.34 Million USD | -2.25% |
2021 FY | 108.53 Million USD | 110.78% |
2020 FY | 51.49 Million USD | 45.06% |
2020 Q1 | 11.16 Million USD | 1.38% |
2020 Q2 | 11.02 Million USD | -1.27% |
2020 Q3 | 11.84 Million USD | 7.41% |
2020 Q4 | 17.45 Million USD | 47.39% |
2019 Q3 | 10.2 Million CAD | -2.84% |
2019 Q2 | 10.49 Million CAD | 67.8% |
2019 Q4 | 11.01 Million CAD | 7.97% |
2019 FY | 35.49 Million CAD | 0.0% |
2019 Q1 | 6.25 Million CAD | 30631.7% |
2018 Q3 | 24.56 Thousand CAD | 28.22% |
2018 Q2 | 19.16 Thousand CAD | -80.34% |
2018 Q1 | 97.46 Thousand USD | 573.16% |
2018 Q4 | 20.36 Thousand CAD | -17.12% |
2017 FY | 127.14 Thousand CAD | 19.95% |
2017 Q2 | -953.10 USD | -103.25% |
2017 Q3 | 16.52 Thousand USD | 1833.5% |
2017 Q1 | 29.35 Thousand USD | 79.9% |
2017 Q4 | 14.47 Thousand USD | -12.37% |
2016 Q2 | 16.61 Thousand USD | 186.26% |
2016 Q1 | 5803.83 USD | -87.39% |
2016 Q3 | 19.05 Thousand USD | 14.68% |
2016 Q4 | 16.31 Thousand USD | -14.37% |
2016 FY | 106 Thousand USD | -68.62% |
2015 Q3 | 112.1 Thousand CAD | -40.43% |
2015 FY | 337.75 Thousand USD | -64.53% |
2015 Q4 | 46.02 Thousand CAD | -58.95% |
2015 Q2 | 188.19 Thousand CAD | 40.36% |
2015 Q1 | 134.07 Thousand CAD | -64.45% |
2014 Q4 | 377.18 Thousand CAD | 63.02% |
2014 FY | 952.32 Thousand CAD | -36.77% |
2014 Q1 | 570.15 Thousand CAD | 66.38% |
2014 Q2 | 233.75 Thousand CAD | -59.0% |
2014 Q3 | 231.36 Thousand CAD | -1.02% |
2013 Q4 | 342.67 Thousand CAD | 0.27% |
2013 FY | 1.5 Million CAD | -2.93% |
2013 Q1 | 258.52 Thousand CAD | -46.74% |
2013 Q2 | 261.64 Thousand CAD | 1.21% |
2013 Q3 | 341.75 Thousand CAD | 30.62% |
2012 Q1 | 757.34 Thousand CAD | 93.26% |
2012 Q2 | 280.26 Thousand CAD | -62.99% |
2012 FY | 1.55 Million CAD | -53.88% |
2012 Q3 | 517.16 Thousand CAD | 84.53% |
2012 Q4 | 485.36 Thousand CAD | -6.15% |
2011 Q3 | 281.8 Thousand CAD | -86.32% |
2011 Q1 | 654.96 Thousand CAD | 14.53% |
2011 Q2 | 2.05 Million CAD | 214.42% |
2011 Q4 | 391.88 Thousand CAD | 39.06% |
2011 FY | 3.36 Million CAD | 67.47% |
2010 FY | 2 Million CAD | 7404.29% |
2010 Q4 | 571.84 Thousand CAD | 57.55% |
2010 Q3 | 362.96 Thousand CAD | 720.92% |
2010 Q1 | 15.45 Thousand CAD | 110.22% |
2010 Q2 | 44.21 Thousand CAD | 186.01% |
2009 Q2 | 3149.54 CAD | -70.02% |
2009 FY | 26.77 Thousand CAD | -27.88% |
2009 Q4 | 7353.84 CAD | 81.24% |
2009 Q3 | 4057.52 CAD | 28.83% |
2009 Q1 | 10.5 Thousand CAD | 44.03% |
2008 FY | 37.12 Thousand CAD | 0.0% |
2008 Q1 | -4219.98 CAD | 0.0% |
2008 Q4 | 7293.07 CAD | 123.98% |
2008 Q3 | 3256.14 CAD | -86.56% |
2008 Q2 | 24.23 Thousand CAD | 674.24% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Aion Therapeutic Inc. | 163.11 Thousand CAD | -82475.519% |
Ayurcann Holdings Corp. | 11.71 Million CAD | -1049.645% |
Blueberries Medical Corp. | 84.22 Thousand CAD | -159822.481% |
The BC Bud Corporation | 1.28 Million CAD | -10398.566% |
BioNxt Solutions Inc. | 6.73 Million CAD | -1898.569% |
CordovaCann Corp. | 3.86 Million CAD | -3388.061% |
Christina Lake Cannabis Corp. | 4.28 Million CAD | -3044.746% |
Captor Capital Corp. | 16.28 Million CAD | -727.242% |
City View Green Holdings Inc. | 705.7 Thousand CAD | -18986.438% |
1CM Inc. | 7.3 Million CAD | -1743.137% |
Global Hemp Group Inc. | 551.7 Thousand CAD | -24314.13% |
Greenway Greenhouse Cannabis Corporation | 4.8 Million CAD | -2701.693% |
IM Cannabis Corp. | 22.63 Million CAD | -494.994% |
Lobe Sciences Ltd. | 4.13 Million CAD | -3159.627% |
Maple Leaf Green World Inc. | 392.21 Thousand CAD | -34241.972% |
Mountain Valley MD Holdings Inc. | 60 Thousand CAD | -224391.183% |
Nextleaf Solutions Ltd. | 1.76 Million CAD | -7518.436% |
Ovation Science Inc. | 54.1 Thousand CAD | -248873.586% |
Pharmadrug Inc. | 1.33 Million CAD | -9989.393% |
Captiva Verde Wellness Corp. | 1.3 Million CAD | -10218.216% |
RAMM Pharma Corp. | 7.48 Million CAD | -1700.636% |
RIV Capital Inc. | 21.1 Million CAD | -538.292% |
Revive Therapeutics Ltd. | 3.28 Million CAD | -3999.402% |
Red White & Bloom Brands Inc. | 37.75 Million CAD | -256.718% |
SLANG Worldwide Inc. | 24.6 Million CAD | -447.41% |
1933 Industries Inc. | 5.12 Million CAD | -2528.065% |
Red Light Holland Corp. | 2.02 Million CAD | -6566.51% |
Top Strike Resources Corp. | 3.63 Million CAD | -3608.808% |
Xebra Brands Ltd. | -308.42 Thousand CAD | 43772.212% |
Adastra Holdings Ltd. | 9.36 Million CAD | -1338.955% |